The newly released Insights Report, “Improvement in Safety Culture Linked to Better Patient and Staff Outcomes,” highlights ...
Once it’s released, the Cradle-to-Career data system could reshape parents’ and students’ decisions and lead to significant ...
In his first year as governor, Gavin Newsom made the creation of a comprehensive, statewide education data system one of his ...
Building internal tools to benchmark energy footprints of cloud usage has become critical to deliver energy savings and ...
Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress
VESPER-2 is a 28-week Phase 2b clinical trial assessing the efficacy and tolerability of different weekly doses of MET-097i with or without titration. The trial enrolled the first participant in March ...
Received a "Study May Proceed” letter from the FDA to evaluate amezalpat in combination with atezolizumab (TECENTRIQ®) and ...
Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...
Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer ...
Elon Musk has sold X, formerly Twitter, to his artificial intelligence startup xAI in an all-stock transaction that has drawn ...
How districts can rethink strategic planning as an agile, living process powered by real-time analytics, continuous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback